Global Candesartan Cilexetil (CAS 145040-37-5) Market Outlook 2016-2021

Choose Licence

 

Candesartan (rINN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand. It is available in generic form. Candesartan is marketed as the cyclohexyl 1-hydroxyethyl carbonate (cilexetil) ester, known as candesartan cilexetil. Candesartan cilexetil is metabolised completely by esterases in the intestinal wall during absorption to the active candesartan moieity. This report provides detailed analysis of worldwide markets for Candesartan Cilexetil (CAS 145040-37-5) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Candesartan Cilexetil (CAS 145040-37-5) market and further lays out an analysis of the factors influencing the supply/demand for Candesartan Cilexetil (CAS 145040-37-5), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. GCCs report, Global Candesartan Cilexetil (CAS 145040-37-5) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Candesartan Cilexetil (CAS 145040-37-5) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Candesartan Cilexetil (CAS 145040-37-5) market are Takeda Pharmaceutical (Japan), Taj Pharmaceuticals (India),Lupin (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), TIPR Pharmaceutical (China), Weihai Disu (China), Zhejiang Huahai (China), Jiangxi Synergy (China), among others. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Candesartan Cilexetil (CAS 145040-37-5) industry has been provided.

 

Part 1. Scope of Report 1.1 Methodology 1.2 Geographic Scope 1.3 Years Considered Part 2. Introduction 2.1 Definition 2.2 Current Scenario 2.2 Future Scenario Part.3 Value Chain Analysis 3.1 Upstream 3.2 Downstream Part 4. Manufacture 4.1 Manufacturing Process 4.2 Issues and Trends 4.3 Manufacturing Costs Part 5. Worldwide Key Vendors 5.1 Company A 5.1.1 Business Overview 5.1.2 Products Offered 5.1.3 Business Performance 5.2 Company B 5.3 Company C 5.4 Company D 5.5 Company E 5.6 Company F 5.7 Company G 5.8 Company H 5.9 Company I 5.10 Company J Part 6. Market Overview 6.1 Global Production Volume 2011-2016 6.2 Production Volume by Region 2011-2016 6.2.1 North America 6.2.2 EMEA 6.2.3 Asia-Pacific 6.2.4 ROW 6.3 Global Production Value 2011-2016 6.4 Production Value by Region 6.4.1 North America 6.4.2 EMEA 6.4.3 Asia-Pacific 6.4.4 ROW Part 7. Consumption Pattern 7.1 Regional Consumption 7.1.1 North America 7.1.2 EMEA 7.1.3 Asia-Pacific 7.1.4 ROW 7.2 Global Consumption by Application Part 8. Market Forecast 8.1 Market Size by Volume 8.1.1 North America 8.1.2 EMEA 8.1.3 Asia-Pacific 8.1.4 ROW 8.2 Market Size by Value 8.2.1 North America 8.2.2 EMEA 8.2.3 Asia-Pacific 8.2.4 ROW 8.3 Regional Consumption Forecast 8.3.1 North America 8.3.2 EMEA 8.3.3 Asia-Pacific 8.3.4 ROW 8.4 Consumption Forecast by Application Part 9. Market Dynamics 9.1 Market Drivers 9.2 Market Constraints 9.3 Market Strategies Part 10 Key Events 10.1 Mergers & Acquisitions 10.2 New Product Launches 10.3 Expansions 10.4 Other Developments

Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production Volume (Unit) 2011-2016 Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) 2011-2016 Figure Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Volume Share 2015 Figure Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value Share 2015 Figure Regional Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) 2015 Figure Regional Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) 2015 Table Raw Material Materials Suppliers Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Pattern 2015 Figure Manufacturing Cost Structure Figure Company A Candesartan Cilexetil (CAS 145040-37-5) Products Table Company A Financial Performance 2011-2016 Figure Company A Market Share 2011-2016 Figure Company B Candesartan Cilexetil (CAS 145040-37-5) Products Table Company B Financial Performance 2011-2016 Figure Company B Market Share 2011-2016 Figure Company C Candesartan Cilexetil (CAS 145040-37-5) Products Table Company C Financial Performance 2011-2016 Figure Company C Market Share 2011-2016 Figure Company D Candesartan Cilexetil (CAS 145040-37-5) Products Table Company D Financial Performance 2011-2016 Figure Company D Market Share 2011-2016 Figure Company E Candesartan Cilexetil (CAS 145040-37-5) Products Table Company E Financial Performance 2011-2016 Figure Company E Market Share 2011-2016 Figure Company F Candesartan Cilexetil (CAS 145040-37-5) Products Table Company F Financial Performance 2011-2016 Figure Company F Market Share 2011-2016 Figure Company G Candesartan Cilexetil (CAS 145040-37-5) Products Table Company G Financial Performance 2011-2016 Figure Company G Market Share 2011-2016 Figure Company H Candesartan Cilexetil (CAS 145040-37-5) Products Table Company H Financial Performance 2011-2016 Figure Company H Market Share 2011-2016 Figure Company I Candesartan Cilexetil (CAS 145040-37-5) Products Table Company I Financial Performance 2011-2016 Figure Company I Market Share 2011-2016 Figure Company J Candesartan Cilexetil (CAS 145040-37-5) Products Table Company J Financial Performance 2011-2016 Figure Company J Market Share 2011-2016 Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2011-2016 Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Share 2011-2016 Figure Global Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit), Capacity Utilization 2011-2016 Figure Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2011-2016 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2011 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2012 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2013 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2014 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2015 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production (Unit) 2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Production Volume (Unit) 2011-2016 Table Global Production Volume (Unit) 2011-2016 Table Global Production Volume Share 2011-2016 Figure North America Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit) Figure North America Production Share Trend Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit) Figure EMEA Production Share Trend Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit) Figure Asia-Pacific Production Share Trend Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Capacity & Production (Unit) Figure ROW Production Share Trend Change Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD), Growth Rate Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2011-2016 Table Global Key Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value Share 2011-2016 Figure Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2011-2016 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2011 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2012 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2013 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2014 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2015 Table Global Top 10 Candesartan Cilexetil (CAS 145040-37-5) Vendors Production Value (M USD) 2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Prices (USD/Ton) 2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Gross Margin 2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) By Region 2011-2016 Table Global Candesartan Cilexetil (CAS 145040-37-5) Production Value (M USD) 2011-2016 Table Global Candesartan Cilexetil (CAS 145040-37-5) Production Value Share 2011-2016 Figure North America Production Value (M USD), Growth Rate Figure North America Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend Figure EMEA Production Value (M USD), Growth Rate Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend Figure Asia-Pacific Production Value (M USD), Growth Rate Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend Figure ROW Production Value (M USD), Growth Rate Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Production Value Share Trend Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2015 Table Regional Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2011-2016 Table Regional Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2011-2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in North America 2011-2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in EMEA 2011-2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in Asia-Pacific 2011-2016 Figure Candesartan Cilexetil (CAS 145040-37-5) Consumption in ROW 2011-2016 Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016 Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2011-2016 Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2011-2016 Figure Global Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Production Share 2016-2021 Figure North Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021 Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021 Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021 Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Production (Unit) Forecast 2016-2021 Figure Global Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Revenue Share 2016-2021 Figure North America Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021 Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021 Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021 Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Revenue (M USD) Forecast 2016-2021 Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2016-2021 Figure North America Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast Figure EMEA Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast Figure Asia-Pacific Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast Figure ROW Candesartan Cilexetil (CAS 145040-37-5) Consumption (Unit) Forecast Figure Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume (Unit) 2016-2021 Table Global Candesartan Cilexetil (CAS 145040-37-5) Consumption Volume Share 2016-2021 Table Key Strategies for Candesartan Cilexetil (CAS 145040-37-5) Multinational Corporations Table Key Strategies for Candesartan Cilexetil (CAS 145040-37-5) Emerging-Market Players

This GCC report is based on the synthesis, analysis, and interpretation of information about the global market collected from specialized sources. GCC analysts have derived insights using a mix of primary and secondary research with an aim to provide a holistic picture of the market. The research methodology used to estimate and forecast the market begins with capturing data on key players’ revenues in the market through secondary research. The bottom-up procedure was employed to obtain the overall market size of the global market. Specific to this market, global market volume & revenue is estimated on the basis of the sales information of key major players.  
 

After arriving at the overall market size, the industry is then divided into several segments and sub-segments which are then verified through primary research by conducting extensive interviews with key people such as CEOs, sales managers, Directors and executives. Drawing on GCC’s research, expert interviews, and extensive experience working with market-facing companies worldwide, main trends that have begun- and will most likely continue-to affect this industry are identified and analyzed.

Other Reports by Gen Consulting Company

Global 2-Acetyl Furan Market Outlook 2017-2022

2-Acetylfuran, or acetyl furan, is a chemical with the formula of C6H6O2. The compound is a useful intermediate in the synthesis of fine chemicals and pharmaceuticals, and is used in the production of the generic cephalophosphorin antibiotic cefuroxi...

Global Pyrrole Market Outlook 2017-2022

Pyrrole is a heterocyclic aromatic organic compound, a five-membered ring with the formula C4H4NH. Pyrrole is a precursor to the drug tolmetin. Polypyrrole is of some commercial value. N-Methylpyrrole is a precursor to N-methylpyrrolecarboxylic acid,...

Global Cyclohexanecarboxylic Acid Market Outlook 2017-2022

Cyclohexanecarboxylic acid is a cyclohexane with a carboxyl group affixed, it has a formula of C7H12O2. The compound is used curing agent, pharmaceutical, and rubber sectors. The report covers forecast and analysis for the cyclohexanecarboxylic acid ...

Global 4-Fluoro-N-isopropylaniline Market Outlook 2017-2022

4-Fluoro-N-isopropylaniline is a derivative of fluorobenzene with the formula of C9H12FN. The compound is used for preparation of agrochemical and pharmaceutical intermediates. The report covers forecast and analysis for the 4-fluoro-N-isopropylanili...

Global SMIA Market Outlook 2017-2022

Syn-2-Methoxy-imino-2-(2-furyl)-acetic acid ammonium salt (SMIA) is an important intermediate for production of Cefuroxime. Cefuroxime is an enteral second-generation cephalosporin antibiotic. It was discovered by Glaxo, now GlaxoSmithKline, and firs...

New Pharmaceuticals and Healthcare Reports